Ben Shofty
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (8)
Roughly one-third of patients with major depressive disorder (MDD) fail to respond to standard treatments and develop treatment-resistant MDD. For these patients, alternative therapies ofer additional options but yield inconsistent outcomes. Progress has been limited by the absence of objective, brain-based biomarkers to guide target selection or track therapeutic response in real time. Instead, clinicians rely on behavioral assessments that evolve slowly over weeks to months, obscuring the underlying neural dynamics of symptom changes. Here, we test whether the aperiodic exponent of intracranial EEG (iEEG) local field potentials can serve as a neurophysiological marker of depression symptom severity. We leveraged a large iEEG cohort (N = 20) undergoing invasive monitoring for refractory epilepsy, yielding over 1,800 contacts spanning cortical and subcortical zones. For each contact, we estimated the aperiodic exponent (thought to reflect aspects of cortical excitability) of the power spectrum across 10-100 Hz within local brain regions and across distributed cortical association networks. Depressive symptoms were assessed with the Beck Depression Inventory-II (BDI-II) immediately before intracranial resting state recordings. With respect to the BDI-II scale, participants were identified as experiencing minimal (BDI-II ≤ 13) or elevated depression symptoms (BDI-II ≥ 14). Associations between symptom severity (BDI-II total score and Somatic-Afective, Cognitive, and Anhedonia subscales) and region- or network-level exponents were modeled with ordinary least squares (OLS) regression. The whole-brain, mean aperiodic exponent for each participant discriminated symptom status (AUC = 0.81). At the regional level, the orbitofrontal cortex, anterior cingulate cortex, insula, and amygdala showed higher exponents in the elevated depression symptom group (d = 1.18-1.71; p = 0.032-0.004). A post-hoc classification analysis across these four regions misclassified one participant per group (AUC = 0.86; 95% CI 0.64-1.00). In continuous analyses, BDI-II scores correlated positively with exponents in these same four regions (pFDR = 0.019-0.027; partial r=0.61–0.70) and at the network level in the Salience network (pFDR = 0.024; partial r = 0.63) and Default (pFDR = 0.046; partial r = 0.55) network. The Salience network significantly tracked Anhedonia symptoms (p = 0.004; partial r = 0.62). Here we report that intracranial aperiodic exponents within fronto-limbic and insular circuits, overlapping with networks implicated in contemporary accounts of depression pathophysiology, diferentiate depressive symptom status and scale with severity. These findings support the aperiodic exponent as a candidate neurophysiological marker of current depression symptom burden, with potential relevance for individualized neuromodulation in MDD.
Year:
2025
Objective To characterize the type and distribution of epileptiform activity across anatomical regions and functional networks in a large cohort of patients with drug-resistant epilepsy (DRE) undergoing intracranial electroencephalography (iEEG). Methods We retrospectively reviewed iEEG recordings from 93 patients with DRE who underwent stereoelectroencephalography at our institution between 2019 and 2025. Epileptiform activity was classified as “ictal”, “interictal”, or “ictal spread” based on visual inspection and clinical correlation. Electrode coordinates were localized to anatomical regions using the Brainnetome Atlas and to functional networks using the DU15NET-Consensus Atlas . The distribution of epileptiform activity across regions and networks was compared with global baselines using Chi-square tests with false discovery rate correction. Results Interictal discharges were the most prevalent type of epileptiform activity (median 9.5% of contacts per patient), followed by ictal (6.0%) and ictal spread (2.1%). Temporal regions exhibited an increased prevalence of all types of epileptiform activity compared to the global baseline, whereas frontal regions showed marked reductions, despite dense sampling. At the network level, epileptiform activity was overrepresented in Default Network-A and underrepresented in the Salience/Parietal Memory Network. Significance Epileptiform activity shows consistent, non-uniform patterns across both anatomical regions and functional networks. These findings reinforce the central role of the temporal lobe and associative networks in epileptogenesis and support the view of epilepsy as a disorder of distributed brain networks. Mapping epileptiform activity in a network framework may enhance biomarker development and inform circuit-based surgical and neuromodulatory treatment strategies.
Year:
2025
Background: Percutaneous cervical cordotomy (PCC) is a lesioning procedure that targets the anterolateral quadrant of the spinal cord to interrupt spinothalamic pain pathways. It provides rapid and durable analgesia for patients with unilateral, medically refractory cancer pain below the C5 dermatome. Although its utilization has declined with the expansion of pharmacological and neuromodulatory therapies, PCC remains a critical palliative intervention for patients in whom opioid therapy is ineffective or intolerable. Summary: This narrative review delineates the neuroanatomical underpinnings, technical evolution, and contemporary clinical outcomes associated with PCC. The procedure is typically performed at the C1–2 level under CT guidance, allowing precise lesion placement verified through impedance monitoring and intraoperative electrophysiological testing. Recent adaptations – including the use of deep sedation combined with neurophysiological mapping – have broadened the eligible patient population to include individuals unable to undergo awake procedures. Across modern clinical series, PCC provides immediate and substantial analgesia in over 90% of patients, frequently enabling significant reductions in opioid consumption and improvements in quality of life. Adverse events are uncommon and typically transient, though hemiparesis, respiratory dysfunction, and mirror pain remain recognized risks. Median post-procedural survival is generally short, reflecting delayed referral patterns and underscoring the need for earlier multidisciplinary consideration. Key Messages: PCC achieves rapid, durable, and substantial analgesia in appropriately selected patients with unilateral, treatment-refractory cancer pain. Advances in imaging and neurophysiological guidance have enhanced procedural accuracy and safety. Earlier integration into palliative care pathways may optimize patient outcomes and quality of life.
Year:
2025
Background: Psychiatric neurosurgery has been shaped by an ethically complex history and rapid evolution in neurotechnology. In the modern era, there is a growing need to match the accelerating pace of scientific innovation with rigorous, contemporary ethical frameworks that prioritize patient autonomy, safety, and maintaining public trust. Summary: In this article, we review 21st-century approaches to neurosurgery for psychiatric disorders that combine the precision of modern functional neurosurgery with advances in diagnostic and therapeutic neurotechnology. The ethical issues in contemporary psychiatric neurosurgery are multifaceted and evolving, reflecting the intersection of rapid scientific progress, changing societal values, and a controversial past. Key Messages: The four core principles of medical ethics – beneficence, nonmaleficence, autonomy, and justice – and their application to psychiatric neurosurgery are discussed in the context of existing and anticipated ethical issues (e.g., post-trial responsibilities in research, informed consent, disparities in access to care). Finally, we explore how technological breakthroughs, coupled with growing market investment and consumer interest in the field, establish a compelling need to develop robust, forward-looking regulatory frameworks that are aligned with these bioethical principles.
Year:
2025
The ability to think creatively is fundamental to human cognition, shaping how we interact with the world and navigate complex problems. Creativity depends on the interaction of multiple large-scale brain networks, but how these networks represent creative thought and distinguish it from other cognitive states remains unclear. Here, we use invasive intracranial recordings in the human brain to explore the network-level representations underlying creative thinking. Our results demonstrate that cortical networks in the human brain differentially encode distinct cognitive states: we found unique brain states underlying creative thinking vs. arithmetic calculations, particularly in the default mode network. Further, in the dorsal attention network, we uncovered nonlinear, high-dimensional representations of moment-by-moment fluctuations in creative performance. These representations define a neural creativity axis shared between network-level and single-neuron computations. Our findings reveal widespread neural representations of cognitive state and suggest distinct roles of specific cortical networks in controlling creativity, with the default mode network gating access to creative states and the dorsal attention network regulating the quality of creative output.
Year:
2025
Objective Delay in referral for epilepsy surgery of patients with drug‐resistant epilepsy (DRE) is associated with decreased quality of life, worse surgical outcomes, and increased risk of sudden unexplained death in epilepsy (SUDEP). Understanding the potential causes of delays in referral and treatment is crucial for optimizing the referral and treatment process. We evaluated the treatment intervals, demographics, and clinical characteristics of patients referred for surgical evaluation at our level 4 epilepsy center in the U.S. Intermountain West. Methods We retrospectively reviewed the records of patients who underwent surgery for DRE between 2012 and 2022. Data collected included patient demographics, DRE diagnosis date, clinical characteristics, insurance status, distance from epilepsy center, date of surgical evaluation, surgical procedure, and intervals between different stages of evaluation. Results Within our cohort of 185 patients with epilepsy (99 female, 53.5%), the mean ± standard deviation (SD) age at surgery was 38.4 ± 11.9 years. In this cohort, 95.7% of patients had received definitive epilepsy surgery (most frequently neuromodulation procedures) and 4.3% had participated in phase 2 intracranial monitoring but had not yet received definitive surgery. The median (1st–3rd quartile) intervals observed were 10.1 (3.8–21.5) years from epilepsy diagnosis to DRE diagnosis, 16.7 (6.5–28.4) years from epilepsy diagnosis to surgery, and 1.4 (0.6–4.0) years from DRE diagnosis to surgery. We observed significantly shorter median times from epilepsy diagnosis to DRE diagnosis ( p < .01) and epilepsy diagnosis to surgery ( p < .05) in patients who traveled further for treatment. Patients with public health insurance had a significantly longer time from DRE diagnosis to surgery ( p < .001). Significance Both shorter distance traveled to our epilepsy center and public health insurance were predictive of delays in diagnosis and treatment intervals. Timely referral of patients with DRE to specialized epilepsy centers for surgery evaluation is crucial, and identifying key factors that may delay referral is paramount to optimizing surgical outcomes.
Year:
2024
Neuromodulation techniques, such as deep brain stimulation, intraoperative brain mapping, and responsive neurostimulation, use electricity to alter brain activity. Despite daily clinical use in thousands of patients, it remains fundamentally unknown how human neurons respond to intracranial stimulation. We address this question at a basic level by characterizing neuronal cell-type specific firing rate responses to single pulses of electrical stimulation of the human brain. We carried out broadly distributed stimulation in 30 patients undergoing neuromonitoring for epilepsy while recording from isolated neurons on microwires implanted into the medial temporal and frontal lobes. Out of a total of 228 recorded units, 16.2% (N = 191) were classified as interneurons and 83.8% (N = 37) were classified as principal cells, using a threshold clustering method, based on intrinsic waveshape characteristics. To see how stimulation affected neuronal activation for each cell type, we calculated firing rate change between a pre-stimulation and post-stimulation window and observed that 174 units were significantly modulated with the vast majority (91%) showing firing rate suppression. We then characterized stimulation-evoked changes in firing rate to gain insight into cell type-specific responses. Additionally, in a subset of the units, we observed that firing rate responses were modulated by stimulation distance, where local stimulation (within approximately 40 mm) could evoke instantaneous firing, whereas distant stimulation reliably suppressed firing in the same units. Finally, we analyzed a subset of units within the seizure onset zone, which exhibited unique waveform features and responses to stimulation. This study bridges a gap in the neuromodulation field by examining the single-unit firing rate response to direct electrical stimulation of the human brain and analyzing cell-type specific firing rate responses. We show that low frequency, single-pulse stimulation broadly elicits firing rate suppression, but parameters, such as distance from the unit, can have diverse effects on firing rate responses. This work informs the neuronal basis of CCEP generation and therefore has implications for clinical mapping and informs novel ‘active probing’ strategies for precision diagnosis and neuromodulation of seizure pathophysiology in surgical cases. Moreover, this research has general implications for understanding neuromodulation via direct brain stimulation. Highlights - Putative principal cell waveform shapes are characterized by longer trough-to-peak and full-width half max durations (s) compared to interneurons. - Monopolar stimulation @ 3 mA generally has a widespread suppressive effect on neuronal firing, lasting approximately 1.5 s. - Principal cells show greater suppression amplitude and longer suppression durations than interneurons. - Stimulation within ∼ 40 mm is capable of evoking instantaneous firing, despite general suppression from stimulation at greater distances.
Year:
2024
The rewards that we get from our choices and actions can have a major influence on our future behavior. Understanding how reward biasing of behavior is implemented in the brain is important for many reasons, including the fact that diminution in reward biasing is a hallmark of clinical depression. We hypothesized that reward biasing is mediated by the anterior cingulate cortex (ACC), a cortical hub region associated with the integration of reward and executive control and with the etiology of depression. To test this hypothesis, we recorded neural activity during a biased judgment task in patients undergoing intracranial monitoring for either epilepsy or major depressive disorder. We found that beta (12–30 Hz) oscillations in the ACC predicted both associated reward and the size of the choice bias, and also tracked reward receipt, thereby predicting bias on future trials. We found reduced magnitude of bias in depressed patients, in whom the beta-specific effects were correspondingly reduced. Our findings suggest that ACC beta oscillations may orchestrate the learning of reward information to guide adaptive choice, and, more broadly, suggest a potential biomarker for anhedonia and point to future development of interventions to enhance reward impact for therapeutic benefit.
Year:
2024
Collaborators (13)
Wendy Sun
Harvard University
Eleonora Bartoli
Assistant Professor
Baylor College of Medicine
Angela Peters
Assistant Professor of Neurology
University of Utah
Sameer Sheth
Baylor College of Medicine
Roger Beaty
Assistant Professor
Pennsylvania State University
John D Rolston
Brigham and Women's Hospital
Sanjay Mathew
Vice Chair for Research
Baylor College of Medicine
Bornali Kundu
Assistant Professor
University of Missouri
Jingnan Du
Assistant Professor
University of Notre Dame
Shervin Rahimpour
Assistant Professor
University of Utah
Elliot Smith
Assistant Professor
University of Utah
Kelly R Bijanki
Assistant Professor, Tenure Track
Baylor College of Medicine
Randy Buckner
Solsland Family Professor of Psychology and Neuroscience
Harvard University
Make your next move.
Prepare your application
Review drafts before you send them.